[{"address1": "5005 McConnell Avenue", "city": "Los Angeles", "state": "CA", "zip": "90066", "country": "United States", "phone": "310 665 2928", "fax": "310 665 2963", "website": "https://www.armatapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Deborah L. Birx M.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 554998, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David D. House", "age": 40, "title": "Senior VP of Finance & Principal Financial Officer", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 352231, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre  Kyme Ph.D.", "age": 46, "title": "Chief Business Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 733062, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hubbard", "title": "Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bani  Tchekanova Ph.D.", "title": "Head of Regulatory Strategy & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.ampliphibio.com/phoenix.zhtml?c=84981&p=irol-stockquote", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.96, "open": 5.08, "dayLow": 4.7, "dayHigh": 4.9965, "regularMarketPreviousClose": 4.96, "regularMarketOpen": 5.08, "regularMarketDayLow": 4.7, "regularMarketDayHigh": 4.9965, "payoutRatio": 0.0, "beta": 1.134, "forwardPE": -3.1273882, "volume": 51944, "regularMarketVolume": 51944, "averageVolume": 241539, "averageVolume10days": 1490190, "averageDailyVolume10Day": 1490190, "bid": 4.94, "ask": 5.0, "bidSize": 3, "askSize": 3, "marketCap": 177888512, "fiftyTwoWeekLow": 0.9, "fiftyTwoWeekHigh": 16.34, "allTimeHigh": 1960000.0, "allTimeLow": 0.83, "priceToSalesTrailing12Months": 25.901064, "fiftyDayAverage": 3.4412, "twoHundredDayAverage": 2.30945, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 317515520, "profitMargins": 0.0, "floatShares": 10874749, "sharesOutstanding": 36229842, "sharesShort": 21970, "sharesShortPriorMonth": 27906, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.00059999997, "heldPercentInsiders": 0.69482005, "heldPercentInstitutions": 0.02023, "shortRatio": 2.4, "shortPercentOfFloat": 0.0021, "impliedSharesOutstanding": 36598781, "bookValue": -1.92, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -25707000, "trailingEps": -1.07, "forwardEps": -1.57, "lastSplitFactor": "1:14", "lastSplitDate": 1557446400, "enterpriseToRevenue": 46.231, "enterpriseToEbitda": -9.368, "52WeekChange": 1.0893617, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 4.91, "targetHighPrice": 9.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 4328000, "totalCashPerShare": 0.119, "ebitda": -33893000, "totalDebt": 143955008, "quickRatio": 0.054, "currentRatio": 0.063, "totalRevenue": 6868000, "revenuePerShare": 0.19, "returnOnAssets": -0.23353, "grossProfits": -27670000, "freeCashflow": -27914376, "operatingCashflow": -31581000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -3.1553698, "financialCurrency": "USD", "symbol": "ARMP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Armata Pharmaceuticals, Inc.", "longName": "Armata Pharmaceuticals, Inc.", "marketState": "CLOSED", "regularMarketPrice": 4.91, "corporateActions": [], "postMarketTime": 1761954703, "regularMarketTime": 1761940800, "exchange": "ASE", "messageBoardId": "finmb_84546611", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.00807, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 769440600000, "postMarketChangePercent": 1.6293263, "postMarketPrice": 4.99, "postMarketChange": 0.07999992, "regularMarketChange": -0.0500002, "regularMarketDayRange": "4.7 - 4.9965", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 241539, "fiftyTwoWeekLowChange": 4.0099998, "fiftyTwoWeekLowChangePercent": 4.4555554, "fiftyTwoWeekRange": "0.9 - 16.34", "fiftyTwoWeekHighChange": -11.43, "fiftyTwoWeekHighChangePercent": -0.6995104, "fiftyTwoWeekChangePercent": 108.936165, "dividendDate": 1557446400, "earningsTimestamp": 1762977600, "earningsTimestampStart": 1762977600, "earningsTimestampEnd": 1762977600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.07, "epsForward": -1.57, "epsCurrentYear": -1.46, "priceEpsCurrentYear": -3.3630135, "fiftyDayAverageChange": 1.4687998, "fiftyDayAverageChangePercent": 0.4268278, "twoHundredDayAverageChange": 2.60055, "twoHundredDayAverageChangePercent": 1.1260474, "priceToBook": -2.5572917, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Armata Pharmaceuticals Inc.", "nameChangeDate": "2025-10-31", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Armata Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]